Difference between revisions of "Antimicrobial prophylaxis"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "https://ascopubs.org/doi/full/10.1200" to "https://doi.org/10.1200") Tags: mobile edit mobile web edit |
Warner-admin (talk | contribs) m (Text replacement - "1 PubMed]" to "1/ PubMed]") |
||
| Line 7: | Line 7: | ||
===Older=== | ===Older=== | ||
| − | * '''2013:''' Flowers et al. [https://doi.org/10.1200/JCO.2012.45.8661 Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline] [https://pubmed.ncbi.nlm.nih.gov/23319691 PubMed] | + | * '''2013:''' Flowers et al. [https://doi.org/10.1200/JCO.2012.45.8661 Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline] [https://pubmed.ncbi.nlm.nih.gov/23319691/ PubMed] |
[[Category:Clinical pharmacology]] | [[Category:Clinical pharmacology]] | ||
[[Category:General reference pages]] | [[Category:General reference pages]] | ||
Revision as of 13:59, 26 April 2023
This is a stub page that will be expanded over time
Guidelines
ASCO/IDSA
- 2018: Taplitz et al. Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update PubMed
- 2018: Taplitz et al. Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update PubMed